 Designer Drugs
"Designer Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
| Descriptor ID |
D015198
|
| MeSH Number(s) |
D26.200
|
| Concept/Terms |
Designer Drugs- Designer Drugs
- Drugs, Designer
- Customized Drugs
- Drugs, Customized
|
Below are MeSH descriptors whose meaning is more general than "Designer Drugs".
Below are MeSH descriptors whose meaning is more specific than "Designer Drugs".
This graph shows the total number of publications written about "Designer Drugs" by people in this website by year, and whether "Designer Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Designer Drugs" by people in Profiles.
-
Fleming SW, Cooley JC, Johnson L, Frazee CC, Domanski K, Kleinschmidt K, Garg U. Analysis of U-47700, a Novel Synthetic Opioid, in Human Urine by LC-MS-MS and LC-QToF. J Anal Toxicol. 2017 Apr 01; 41(3):173-180.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|